1
|
Kasamatsu A, Fukushima K, Igarashi Y, Mitarai S, Nagata Y, Horiuchi M, Sekiya N. Vertebral Osteomyelitis Caused by Mycobacterium arupense Mimicking Tuberculous Spondylitis: First Reported Case and Literature Review. Open Forum Infect Dis 2023; 10:ofad019. [PMID: 36726542 PMCID: PMC9887264 DOI: 10.1093/ofid/ofad019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/29/2022] [Accepted: 01/12/2023] [Indexed: 01/18/2023] Open
Abstract
Mycobacterium arupense is a slow-growing, nontuberculous mycobacterium widely found in the environment and is known to cause tenosynovitis and osteomyelitis, mainly in the hands and wrists. We present the first case of vertebral osteomyelitis caused by M arupense in a 78-year-old man with renal cell carcinoma. The patient had a history of tuberculous pleuritis in childhood. Although the nucleic acid amplification test of the vertebral tissue for Mycobacterium tuberculosis was negative, we initiated tuberculosis treatment based on the history and pathological findings of auramine-rhodamine-positive organisms and epithelioid cell granulomas. Subsequently, the isolated mycobacterium was identified as M arupense by genome sequencing. Accordingly, the treatment regimen was changed to a combination of clarithromycin, ethambutol, and rifabutin. Owing to a subsequent adverse event, rifabutin was switched to faropenem, and the patient was treated for a total of 1 year. In previous literature, we found 15 reported cases of bone and soft tissue infections caused by M arupense, but none of them had vertebral lesions. Physicians should be aware that M arupense can cause vertebral osteomyelitis mimicking tuberculous spondylitis. In addition, molecular testing of isolated mycobacteria is essential for diagnosis, even if tuberculous spondylitis is suspected.
Collapse
Affiliation(s)
- Ayu Kasamatsu
- Department of Infectious Diseases, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan,Department of Infection Prevention and Control, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan
| | - Kazuaki Fukushima
- Correspondence: Kazuaki Fukushima, MD, Department of Infectious Diseases, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Hon-komagome, Bunkyo-ku, Tokyo 113-8677, Japan (); Noritaka Sekiya, MD, Department of Infection Prevention and Control, Department of Clinical Laboratory, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Hon-komagome, Bunkyo-ku, Tokyo 113-8677, Japan ()
| | - Yuriko Igarashi
- Department of Mycobacterium Reference and Research, Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Tokyo, Japan
| | - Satoshi Mitarai
- Department of Mycobacterium Reference and Research, Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Tokyo, Japan
| | - Yuka Nagata
- Department of Infection Prevention and Control, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan
| | - Masao Horiuchi
- Department of Infection Prevention and Control, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan
| | - Noritaka Sekiya
- Correspondence: Kazuaki Fukushima, MD, Department of Infectious Diseases, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Hon-komagome, Bunkyo-ku, Tokyo 113-8677, Japan (); Noritaka Sekiya, MD, Department of Infection Prevention and Control, Department of Clinical Laboratory, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Hon-komagome, Bunkyo-ku, Tokyo 113-8677, Japan ()
| |
Collapse
|
2
|
Navid S, Sadegh-Ehdaei B, Shabani M, Hasani M, Mirzaei A, Ghazvini K, Youssefi M, Keikha M. The case report of Mycobacterium arupense wound infection in diabetes mellitus patients; the first report and literature review. Access Microbiol 2020; 2:acmi000106. [PMID: 33005870 PMCID: PMC7523626 DOI: 10.1099/acmi.0.000106] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/05/2019] [Accepted: 01/09/2020] [Indexed: 02/05/2023] Open
Abstract
Mycobacterium arupense is among the opportunist pathogens of atypical mycobacteria emergence (atypical mycobacteria) that is one of the isolated and reported environmental and clinical specimens. Numerous cases of osteo-articular infections of this bacterium are reported nowadays, while the pulmonary infection is rare. We identified Mycobacterium arupense in non-healing wound infection of an elderly woman with history of diabetes mellitus. She has negative tests for HIV, HBV and HCV, but was positive for HTLV-1. The patient was referred according to mild-fever, non-healing, destructive, and swelled lesion on her left foot. The mycobacterial wounds infection was suspected due to her non-conclusive previous treatment. The pathology, acid-fast staining, conventional and 16S rRNA sequencing confirmed the micro-organism to be M. arupense. Finally, the patient recovered following two-week consumption of clarithromycin, ethambutol and rifabutin. The results of this study provide evidence on the potential pathogenicity, clinical outcomes and treatment of infections caused by this bacterium.
Collapse
Affiliation(s)
- Sepehr Navid
- Department of Microbiology, School of Medicine, Isfahan Medical University, Isfahan, Iran
| | - Bahar Sadegh-Ehdaei
- Department of Microbiology, School of Medicine, Isfahan Medical University, Isfahan, Iran
| | - Mehdi Shabani
- Department of Microbiology, School of Medicine, Isfahan Medical University, Isfahan, Iran
| | - Melika Hasani
- M.Sc. of Molecular Genetics, Sana Institue of Higher Education, Sari, Iran
| | - Arezoo Mirzaei
- Department of Microbiology, School of Medicine, Isfahan Medical University, Isfahan, Iran
| | - Kiarash Ghazvini
- Antimicrobial Resistance Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.,Department of Microbiology and Virology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Masoud Youssefi
- Antimicrobial Resistance Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.,Department of Microbiology and Virology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Masoud Keikha
- Antimicrobial Resistance Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.,Department of Microbiology and Virology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
| |
Collapse
|
3
|
Zhou X, Ruan Q, Jiang W, Wang X, Jiang Y, Yu S, Xu Y, Li J, Zhang Y, Zhang W, Hu Y. Isolation of Mycobacterium arupense from pleural effusion: culprit or not? BMC Infect Dis 2018; 18:221. [PMID: 29764381 PMCID: PMC5952631 DOI: 10.1186/s12879-018-3136-3] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/09/2018] [Accepted: 05/07/2018] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Mycobacterium arupense, first identified in 2006, is a slow-growing nontuberculous mycobacterium (NTM) and an emerging cause of tenosynovitis, potentially associated with immunosuppression. However, unlike the diagnostic value of its isolation from osteoarticular specimens, the significance of detecting M. arupense in respiratory specimens is not yet clear. CASE PRESENTATION To our knowledge, we, for the first time, described the identification of M. arupense from the pleural effusion of an immunocompetent patient, who presented with fever and chylothorax. The symptoms resolved with doxycycline treatment for 45 days and a low-fat, high-protein diet. Follow-up at 14 months showed no relapse. CONCLUSIONS Because the patient fully recovered without combined anti-NTM treatment, we did not consider M. arupense the etiological cause in this case. This indicates that M. arupense detected in pleural effusion is not necessarily a causative agent and careful interpretation is needed in terms of its clinical relevance.
Collapse
Affiliation(s)
- Xian Zhou
- Department of Infectious Diseases, Huashan Hospital, Fudan University, 12 M. Wulumuqi Road, Shanghai, 200040, China
| | - Qiaoling Ruan
- Department of Infectious Diseases, Huashan Hospital, Fudan University, 12 M. Wulumuqi Road, Shanghai, 200040, China
| | - Weimin Jiang
- Department of Infectious Diseases, Huashan Hospital, Fudan University, 12 M. Wulumuqi Road, Shanghai, 200040, China
| | - Xinyu Wang
- Department of Infectious Diseases, Huashan Hospital, Fudan University, 12 M. Wulumuqi Road, Shanghai, 200040, China
| | - Yuan Jiang
- Shanghai Municipal Center for Disease Control and Prevention, Shanghai, China
| | - Shenglei Yu
- Department of Infectious Diseases, Huashan Hospital, Fudan University, 12 M. Wulumuqi Road, Shanghai, 200040, China
| | - Yu Xu
- Department of Laboratory Medicine, Huashan Hospital, Fudan University, Shanghai, China
| | - Jing Li
- Shanghai Municipal Center for Disease Control and Prevention, Shanghai, China
| | - Yangyi Zhang
- Shanghai Municipal Center for Disease Control and Prevention, Shanghai, China
| | - Wenhong Zhang
- Department of Infectious Diseases, Huashan Hospital, Fudan University, 12 M. Wulumuqi Road, Shanghai, 200040, China
| | - Yuekai Hu
- Department of Infectious Diseases, Huashan Hospital, Fudan University, 12 M. Wulumuqi Road, Shanghai, 200040, China.
| |
Collapse
|
4
|
Mycobacterium arupense: A review article on an emerging potential pathogen in the Mycobacterium terrae complex. J Clin Tuberc Other Mycobact Dis 2017; 10:1-5. [PMID: 31720378 PMCID: PMC6830158 DOI: 10.1016/j.jctube.2017.11.001] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2017] [Revised: 11/14/2017] [Accepted: 11/21/2017] [Indexed: 11/21/2022] Open
|